US steps up probes into pharmaceutical, chip imports, setting stage for tariffs
- QUANTUNG PHARMA
- Apr 14
- 1 min read
Updated: Apr 15
Summary
Trump sets stage to proceed on pharma, chip levies under national security umbrella
Federal Register filings kick off 21-day public comment period
Broad use of tariffs by Trump has roiled markets, sparked economic outlook downgrades
April 14 (Reuters) - The Trump administration is proceeding with probes into imports of pharmaceuticals and semiconductors as part of a bid to impose tariffs on both sectors on grounds that extensive reliance on foreign production of medicine and chips is a national security threat, Federal Register filings on Monday showed.
The filings announce 21-day public comment periods and mark President Donald Trump's latest use of Section 232 of the Trade Expansion Act of 1962 as justification for so-called sectoral tariffs aimed at boosting domestic production of goods he says are critical to national security.
